To strengthen domestic vaccine development and production system, the government plans to make a cabinet decision on a long-term strategy early next month, and clinical research in the Asian region to expedite the large-scale clinical trials necessary for development. It is expected that the development environment will be improved by enhancing the network and the network.
In order to develop vaccines and strengthen the production system, which lags behind Europe and the United States, the government is proceeding with the examination of necessary policies in the future as a long-term strategy at a council formed by related parties such as related ministries and research institutes. The policy is to make a cabinet decision early next month.
Toward this end, a draft proposal has been clarified, and regarding the improvement of the clinical trial environment necessary for vaccine development, "In the case of vaccines, it is necessary to secure subjects in units of tens of thousands, but in Japan, We have never experienced such a large-scale clinical trial, "he said. He said that he would enhance clinical research and networks in the Asian region in order to expedite large-scale clinical trials.
In addition, while medicines such as cancer and hypertension are expected to generate stable profits, infectious diseases do not know when and how large they will occur, and it is economical for companies to actively work on vaccine development from normal times. As it is not rational, the government will consider purchasing it when a new infectious disease occurs.
The government will present a long-term strategy that incorporates these policies at the "Vaccine Summit," a summit meeting co-sponsored by Japan and international organizations scheduled for the 2nd of next month.